Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ACROBiosystems ACROBiosystems Anti-Bevacizumab Antibodies (recommended for ADA assay)
Supplier: ACROBiosystems BEBY9100UG
Antibody;100UG;IgG1/kappa;Recognizes Bevacizumab specifically, no cross reactivity with other humanized antibodies.;Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.; ;Anti-Bevacizumab Antibodies bridging ELISA for Anti-Drug Antibody (ADA) assay development. Immobilized bevacizumab at 0.1 µg/mL, add increasing concentrations of Anti-Bevacizumab Antibodies (recommended for ADA assay) (Cat. No. BEB-Y9, 10% human serum) and then add biotinylated bevacizumab at 5 µg/mL. Detection was performed using HRP-conjugated streptavidin with a sensitivity of 9 ng/mL. ;Demonstration of the specificity of Anti-Bevacizumab Antibodies (recommended for ADA assay) (Cat. No. BEB-Y9) to the bevacizumab.;Anti-Bevacizumab Antibodies (recommended for ADA assay) (mouse IgG1, Cat. No. BEB-Y9) captured on CM5 chip via anti-mouse antibodies surface, can bind human bevacizumab with an a
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?